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http://www.behavioralandbrainfunctions.com/content/8/1/31RESEARCH Open AccessA genetic association study of DNA methylation
levels in the DRD4 gene region finds associations
with nearby SNPs
Sophia J Docherty*, Oliver SP Davis, Claire MA Haworth, Robert Plomin, Ursula D’Souza and Jonathan MillABSTRACT
Background: Dopamine receptor D4 (DRD4) polymorphisms have been associated with a number of psychiatric
disorders, but little is known about the mechanism of these associations. DNA methylation is linked to the
regulation of gene expression and plays a vital role in normal cellular function, with abnormal DNA methylation
patterns implicated in a range of disorders. Recent evidence suggests DNA methylation can be influenced by
cis-acting DNA sequence variation, that is, DNA sequence variation located nearby on the same chromosome.
Methods: To investigate the potential influence of cis-acting genetic elements within DRD4, we analysed DRD4
promoter DNA methylation levels in the transformed lymphoblastoid cell-line DNA of 89 individuals (from
30 family-trios). Five SNPs located +/−10kb of the promoter region were interrogated for associations with DNA
methylation levels.
Results: Four significant SNP associations were found with DNA methylation (rs3758653, rs752306, rs11246228 and
rs936465). The associations of rs3758653 and rs936465 with DNA methylation were tested and nominally replicated
(p-value < 0.05) in post-mortem brain tissue from an independent sample (N = 18). Interestingly, the DNA
methylation patterns observed in post-mortem brain tissue were similar to those observed in transformed
lymphoblastoid cell line DNA.
Conclusions: The link reported between DNA sequence and DNA methylation offers a possible functional role to
seemingly non-functional SNP associations. DRD4 has been implicated in several psychiatric disease phenotypes
and our results shed light upon the possible mode of action of SNP associations in this region.Background
DRD4, which encodes a G-protein-coupled dopamine
receptor [1], has been widely implicated in the etiology
of neuropsychiatric disease. Genetic associations have
been reported between DRD4 and ADHD [2-6], anorexia
[7], schizophrenia [8,9], depression [10,11], obesity [12],
addiction [13] and personality disorders [14]. Although
some of these genetic associations are supported by evi-
dence of altered DRD4 expression in specific diseases
[11,15,16], the mechanism by which DRD4 polymorph-
isms influence behaviour remains unknown. Epigenetic
functions may offer some explanation. Epigenetics refers
to the reversible regulation of various genomic functions* Correspondence: sophia.docherty@iop.kcl.ac.uk
King’s College London, MRC Social, Genetic and Developmental Psychiatry
Centre,, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5
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reproduction in any medium, provided the ormediated through partially stable modifications of DNA
and histone codes, excluding DNA sequence changes.
Epigenetic processes, including histone modification and
DNA methylation, are intrinsically connected to gene
expression, allowing the regulation of gene function
through non-mutagenic means [17]. The methylation of
CpG dinucleotides, which are overrepresented in the
promoter regions of many genes, acts to obstruct cells’
transcriptional machinery and silences gene expression.
Correct control of DNA methylation is vital to normal
cellular function, and DNA methylation dysfunction has
been linked to a number of human pathologies [18,19],
including complex neuropsychiatric phenotypes such as
schizophrenia and bipolar disorder [20]. Though sto-
chastic factors have been implicated [21], there is grow-
ing evidence for the importance of both environmental
and genetic factors in the influence of DNA methylation.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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methylation patterns of dizygotic (DZ) twins relative to
monozygotic (MZ) twins, and heritability estimates of
0.20-0.97 have been generated for DNA methylation
levels within various genomic regions [22,23]. A SNP in
MTHFR – the gene encoding 5,10-methylenetetrahydro-
folate reductase which is involved in the maintenance of
DNA methylation patterns – has been linked to global
DNA methylation levels [24,25]. Furthermore, several
studies have demonstrated cis-acting genetic associations
with DNA methylation in humans, chimpanzees and
mice [20,26-34]. Crucially, as these genetic associations
with DNA methylation levels have also been shown to
correlate with levels of gene expression [33-36], they
could represent the mechanism behind allele-specific
gene expression, which has been commonly reported
throughout the genome [37-40].
A function for previously unexplained genetic associa-
tions may therefore lie in the connection between DNA
methylation and DNA sequence. If this is the case, fur-
ther investigation of such markers might involve asses-
sing their influence over local DNA methylation
patterns. Yet several studies of DNA methylation report
contradictory findings, indicating that the importance of
genetic factors may vary across genomic regions, tissues
and environments [23,41,42]. Thorough analysis in rele-
vant tissues is therefore necessary to draw conclusions
about any one gene of interest.
In the present study, we assess the potential influence
of cis-acting genetic polymorphisms in mediating DNA
methylation at 9 CpG sites across the DRD4 promoter
region, using lymphoblastoid cell-lines from a familial
sample, and post-mortem brain tissue from an inde-
pendent set of individuals.
Methods
Samples
CEPH
We obtained 89 high-quality Centre d'Etude du Poly-
morphisme Humain (CEPH) genomic DNA samples
extracted from transformed lymphoblastoid cell lines
(Coriell Institute for Medical Research, NJ, USA). All
samples were tested for degradation and quantified in
triplicate using fluorimetry, employing PicoGreenW
dsDNA quantitation reagent (Cambridge Bioscience,
UK). Aliquots of each sample were diluted 1:5 with TE
buffer (10 mM Tris, 1 mM EDTA) to a working concen-
tration of 50 ng/μl.
Brain samples
Post-Mortem brain samples were obtained from the 18
individuals archived in the MRC London Brainbank for
Neurodegenrative Disease (Maudsley Brain Bank, De-
partment of Neuropathology, Institute of Psychiatry,London, UK). Brain tissue samples from normal (N= 7;
2 females and 5 males) and Alzheimer’s patients (N = 11;
6 females and 5 males) were used, with agonal states in-
cluding: Bronchopneumonia, cardiac failure, hyperten-
sion, Pulmonary Embolus, Sideroblastic anaemia,
coronary occlusion, carcinoma of left kidney, Myocardial
Infarction and Ischemic heart disease. Tissue was
obtained from multiple brain regions from each patient:
striatum, cerebellum, mid-brain, superior frontal gyrus
(SFG) and superior temporal gyrus (STG). Data from the
Allen Brain Atlas showed DRD4 to be expressed in these
tissues (Allen Brain Atlas Resources [Internet]. Seattle
(WA): Allen Institute for Brain Science. ©2009. Available
from: http://www.brain-map.org). Tissue samples were
between 0.5-1g and stored at −70°C, prior to use. Total
DNA was prepared from homogenized tissue using the
Qiagen Allprep DNA mini kit.
DNA methylation analysis
Bisulfite-PCR primers spanning a region in the DRD4
promoter were designed using the online Sequenom Epi-
Designer software (www.epidesigner.com). Sodium bisul-
fite treatment was performed on 375 ng of each CEPH
sample using the EZ-96 DNA Methylation Kit (Zymo
Research, CA, USA) following the manufacturers’
standard protocol. The DNA of all 89 individuals was
bisulfite converted in the same 96-well plate, with
fully-methylated (a methylation level of 100%) and
unmethylated DNA (0% methylation) samples included
as assay controls. Bisulfite-PCR amplification was con-
ducted using Hot Star Taq DNA polymerase (Qiagen,
UK) and cycling conditions of 45 cycles with an
annealing temperature of 56°C. The primers (F: GGG
ATTTTTTGTTTAGGGTTAGAGG, R: CACCCTAA
TCCACCTAATATCTAACA) amplified the region
chr11:626,509-626,904, assessing 19CpG units (32 CpG
sites). DNA methylation analysis was conducted using
the Mass-spectrometry-based Sequenom EpiTYPER
system (Sequenom Inc, CA, USA), as described previ-
ously [43,44]. The entire experiment, from sodium
bisulfite treatment onwards, was subsequently repeated
in duplicate to control for technical variation.
To optimise reliability, the data produced were subject
to a number of quality control measures. CpG site-
containing fragments with a mass outside the range
measurable by the Sequenom Epi-Typer system were
excluded from further analyses. CpG site-containing
fragments with equal or overlapping masses – making
them irresolvable by mass spectrometry – were also
excluded. CpG site-containing fragments whose meas-
urement was potentially confounded by single nucleotide
polymorphisms according to dbSNP build 130 were also
discarded. This included fragments containing SNPs
which had either been shown to effect populations of
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populations. Fragments whose enzyme cut-sites could be
affected by SNPs were also excluded. As bisulfite treat-
ment converts cytosines to thymines, fragments contain-
ing a C/T SNP on the assayed strand were not excluded,
unless this SNP was within a CpG position. Finally, CpG
site-containing fragments with >33.33% missing data
were excluded. Additional file 1 details the exclusions.
To minimize technical variability, the remaining methy-
lation data were averaged across the two replicates (the
average correlation between the first and second round
DNA methylation levels across the nine CpG units was
0.81). All subjects had < 25% missing DNA methylation
data. The mean of the DNA methylation values for all
CpG sites was calculated in order to gauge the average
DNA methylation level in each subject.
SNP Genotyping
SNP genotypes for the extensively investigated CEPH
sample (see [45] for further description) were down-
loaded from the HapMap website on April 8th 2009
(http://hapmap.ncbi.nlm.nih.gov/ - HapMap Rel 27
Phase II + III, Feb 09, NCBI 36 assembly, dbSNP b126).
Genotypes for SNPs within 10kb up- and downstream of
the DNA methylation-assayed region were downloaded.
6 SNPs with an MAF <0.05 were excluded from the ana-
lysis. The remaining SNP genotypes for the 89 indivi-
duals within our sample were input into Haploview,
where the ‘tagger’ function was used, with an r2 thresh-
old of 0.8, to select 5 SNPs offering optimum coverage
(rs11246221, rs3758653, rs752306, rs11246228,
rs936465) of the region [46]. All SNPs were in Hardy-
Weinberg equilibrium at the p > 0.01 level. Figure 1
graphically depicts the DRD4 gene region investigated.
The significant associations of two SNPs – rs3758653
and rs936465 – were tested for replication in the 18
Maudsley Brain Bank samples. The SNPs were geno-
typed via restriction enzyme digestion of PCR products,
followed by size descrimination using gel electrophor-
esis. The primers CCCTCCACTCCAGGCCTCCC and
CCTCCATTCCCTCCGGCCCA were used to amplify aDRD4 
Figure 1 Positional overview of DRD4 region investigated for SNP ass
Black box = region assessed for DNA methylation. Diagram created using d
(http://hapmap.ncbi.nlm.nih.gov/).347bp region surrounding rs3758653, which was then
digested using EcoRI according to the manufacturer’s
instructions. EcoRI cuts the PCR product only if the C
allele is present. The primers GCTGCCACCCTACCC
CAGGT and GCACTGGGCTGGGCCTGAAC were
used to amplify a 203bp region surrounding rs936465,
which was then digested with Hpy166II according to the
manufacturer’s guidelines. Hpy166II selectively cuts the
PCR product if the G allele is present on the genomic +
strand. Both SNPs had an MAF> 0.05 and were in
Hardy-Weinberg equilibrium at the p > 0.01 level.
Statistical Analyses
The Sequenom Epityper system measures DNA methyla-
tion levels as a proportion: 0 (unmethylated) to 1 (fully-
methylated). The DNA methylation data was therefore
bounded by 0 and 1, and CpG sites with average methy-
lation levels close to these boundaries had a truncated
variance. To overcome the problem of skewed variance,
the DNA methylation data were arcsine transformed.
The data were then normalised using a Van der Waer-
den transformation and standardized to a mean of 0 and
standard deviation of 1. Sex was not associated with
DRD4 DNA methylation and so was not controlled for
in our analyses. Each SNP was tested for association
with the average DNA methylation level across all CpGs
measured in the CEPH sample, using linear mixed
effects models in R [47]. SNP genotype was entered as a
fixed effect into the model. As the sample consisted of
trios, the genetic relatedness between mother and off-
spring, and father and offspring, was controlled for as a
random effect in the model. We were also able to con-
trol for the environment shared by each nuclear family.
Unfortunately, our sample size was too small to accur-
ately test for population stratification, however, as our
sample consisted of CEPH individuals of European an-
cestry, and as all SNPs were in Hardy-Weinberg equilib-
rium, we would not expect significant population
stratification. As the SNPs were correlated, we used Li
and Ji’s method to estimate the effective number of SNPs
tested (MeffLi [48]; calculated at http://gump.qimr.edu.ociations with DNA methylation. White boxes = exons;
ata from UCSC (http://genome.ucsc.edu/) and HapMap
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ferroni method to correct for multiple testing. SNPs
exhibiting an association with overall DNA methylation
levels were then tested for association with each individ-
ual CpG unit within a region. Effect sizes were estimated
from Ns and Chi2 values using an online Effect Size Cal-
culator (http://myweb.polyu.edu.hk/~mspaul/calculator/
calculator.html).
For the post-mortem brain samples, the DRD4 DNA
methylation data were transformed and standardized
using the methods described above. Sex and Alzheimer’s
status were not associated with DRD4 DNA methylation
and so were not controlled for in our analyses.
rs3758653 and rs936465, the two strongest associations,
were tested for association with average DNA methyla-
tion across all CpGs in each available brain tissue type
using linear regression in R. Nominally significant asso-
ciations were investigated further by testing the SNP’s
association with individual CpG sites.
Power
Power was estimated using the Genetic Power Calcula-
tor [50]. Under the additive association model used, at
the p < 0.05 level our sample of 89 individuals from 30
CEPH trios had 80% power to detect a causal variant of
20% allele frequency and 9.6% effect size; and a marker
in linkage disequilibrium (D’= 0.8) with a causal variant
of 20% allele frequency and 15.1% effect size. Our sam-
ple of 18 post-mortem brain samples had 80% power to
detect a causal variant of 20% allele frequency and 41.5%
effect size; and a marker in linkage disequilibrium
(D’= 0.8) with a causal variant of 20% allele frequency
and 64.8% effect size.
eQTL assessment
SNPs demonstrating significant associations with DNA
methylation in the CEPH sample were assessed for
eQTL status using SCAN (http://www.scandb.org) [51].
This online resource contains association p-values be-
tween genotype and expression data generated from the
transformed lymphoblastoid cell lines of CEPH and YRI
(Yoruba subjects from Ibadan, Nigeria) subjects included
in the HapMap project [45].
Results
SNP associations with average DNA methylation levels
Figure 1 graphically depicts the gene region investigated
in this study. The mean DNA methylation level across
this region within our CEPH transformed lymphoblas-
toid cell line sample was 0.61, and the standard deviation
was 0.13. Table 1 displays the results of SNP association
analyses of the average DRD4 DNA methylation level.
The relatedness of the CEPH sample was controlled for
in the analyses. Mean DNA methylation values across allCpGs were used, however, the first principal component
generated from principal components analysis produced
similar results (results not shown). Significant SNP asso-
ciations are represented in Figure 2, with average DNA
methylation plotted against genotype. 4 out of 5 investi-
gated SNPs showed significant associations with average
DNA methylation (rs3758653: N= 81; d.f. = 1; Chi2 =
12.02; P-value = 0.001, rs752306: N = 81; d.f. = 1; Chi2 =
6.78; P-value = 0.009; rs11246228: N= 81; d.f. = 1;
Chi2 = 8.67; P-value = 0.003, rs936465: N = 89; d.f. = 1;
Chi2 = 10.61; P-value = 0.001). The effect sizes of these
associations were substantial – with rs3758653,
rs752306, rs11246228 and rs936465 respectively
accounting for 14.8%, 8.4%, 10.7% and 11.9% of the
variance in average DNA methylation across the DRD4
region in our sample – although the absolute differ-
ences in DNA methylation values across genotype
groups were small to modest. Although the ranges of
DNA methylation shown in Figure 2 are distinct for
opposing homozygote groups, both groups overlap
with the heterozygote group at all SNPs. The associa-
tions remained significant after Bonferroni correction
for the 4 effective SNP tests conducted (MeffLi) [48].
As the sample contained only one TT homozygote at
rs752306 the TT and CT groups were collapsed for
the association analyses. When the true genotypes
were used the association remained nominally signifi-
cant (N= 81; d.f. = 1; Chi2 = 9.45; P-value = 0.002).
Figure 3 displays the LD pattern between the 5 DRD4
SNPs tested in our sample. The four extra SNPs whose
associations were captured (according to the Haploview
‘tagger’ function at r2 > 0.8) are also included in Figure 3.
The high LD shown between rs11246226, rs11246228,
rs7395429, rs936465, rs4331145 and rs11246234 sug-
gests that the significant associations of rs11246228 and
rs936465 (and by proxy, the four other SNPs) with DNA
methylation are likely to reflect the same effect. As the
CEPH population has been extensively genotyped, one
of these SNPs could be the influential variant. As
rs3758653 and rs752306 exhibit generally weaker LD
relationships, they may reflect independent effects.
When the effects of rs3758653 and rs936465 are consid-
ered together, the association with average DRD4 DNA
methylation is stronger (N = 81; d.f. = 2; Chi2 = 16.38; P-
value = 2.79E-04), further suggesting the effects of
rs3758653 and rs936465 may be independent. As might
be expected from Figure 3, adding rs752306 and
rs11246228 does not further increase the strength of the
association (N= 81; d.f = 4; Chi = 18.79; P-value = 0.001).
Similarly, haplotype analyses of rs3758653, rs752306,
rs11246228 and rs936465 in UNPHASED [24] also indi-
cated independence in the effects of rs3758653 and
rs936465, with rs752306 and rs11246228 exerting no
extra effects (data not shown).
Table 1 SNP associations with average DNA methylation levels in the DRD4 promoter region
Gene region DNA Methylation
assessed region
SNP Position N Allele A Allele B Allele A Freq Mean AA Mean AB Mean BB Chi P-value
DRD4 chr11:626,509-626,904 rs11246221 620124 81 A G 0.69 0.62 0.62 0.52 1.79 0.181
rs3758653 626399 81 C T 0.22 0.49 0.57 0.65 12.02 0.001
rs752306 627622 81 C T 0.93 0.63 0.52 - 6.78 0.009
rs11246228 631563 81 C T 0.28 0.64 0.66 0.57 8.67 0.003
rs936465 633568 89 C G 0.42 0.66 0.64 0.54 10.61 0.001
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methylation to also show associations with gene expres-
sion, the four significant cis SNP associations were
investigated further using the online tool SCAN, which
contains p-values from association tests of genotype and
expression data from the transformed lymphoblastoid0
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Figure 3 LD pattern (a =D’, b = r2) across 9 SNPs associated with average DNA methylation in the DRD4 gene region.
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identified.
Many CpG sites were removed from this study during
the stringent quality control process. Some of the CpG
units excluded from the analysis of the DRD4 region are
of interest because the existence of CpG sites depends
on SNP genotypes. CpG site 29 on CpG unit 28.29 may
be affected in this way by rs12720379 genotype.
rs3758653 and rs752306 showed significant associations
with DNA methylation at CpG unit 28.29. In most cases
the correlations of CpG unit 28.29 with those showing
strong SNP associations in the initial analyses of the
DRD4 region are significant and modest (0.23-0.41).
Though rs12720379 is an unvalidated SNP which has yet
to be tested in a sample of European ancestry, its influ-
ence over the presence of a CpG site, and therefore the
presence of DNA methylation, can not be ruled out.
Neither, therefore, can its possible role in the significant
SNP associations reported here.Table 2 SNP associations with DNA methylation at CpGs
within the DRD4 gene region
P-values
CpG unit bp position rs3758653 rs752306 rs11246228 rs936465
8 @107 0.379 0.212 0.510 0.082
9 @113 0.135 0.791 0.225 0.083
12.13.14 @139, 149 & 151 0.027 0.248 0.001 0.007
15.16.17 @159, 168 & 170 0.007 0.075 0.015 0.012
21.22.23 @221, 224 & 227 0.007 0.039 0.125 0.077
32 @288 0.652 0.358 0.486 0.418
36 @310 0.148 0.184 0.027 0.006
37.38 @339, 346 0.000 0.047 0.002 0.011
39 @351 0.019 0.005 0.076 0.295SNP associations with individual CpG units in the DRD4
gene region
We explored the 4 significant SNP associations with
average DRD4 methylation levels further. Table 2 con-
tains p-values from the association analyses of
rs3758653, rs752306, rs11246228 and rs936465 with
DNA methylation at individual DRD4 CpG units, and
Figure 4 plots average DNA methylation levels by geno-
type group at the 4 associated SNPs. The EpiTyper sys-
tem was unable to resolve all CpG sites, and so while
some of the measured CpG units refer to a single CpG
site, many reflect average levels of DNA methylation
across multiple CpG sites. The similar patterns of associ-
ation seen between rs11246228 and rs936465 reflect the
modest LD between these two SNPs shown in Figure 3.
The significant associations of rs11246228 and rs936465,
as well as of rs3758653, with CpG units 12.13.14,
15.16.17, 21.22.23, 36 and 37.38 reflect the modest cor-
relations between DNA methylation levels across these
sites – shown in Figure 5’s heatmap displaying the simi-
larities in DNA methylation levels across the measured
DRD4 region.
Association of rs3758653 and rs936465 with DRD4 DNA
methylation in post-mortem brain samples from five
brain regions
DRD4 is known to be expressed widely in the brain [52]
(Allen Brain Atlas Resources [Internet]. Seattle (WA):
Allen Institute for Brain Science. ©2009. Available from:
http://www.brain-map.org). As they appeared to repre-
sent independent effects, we tested the association of
rs3758653 and rs936465 with DRD4 DNA methylation
for replication within a sample of post-mortem brain tis-
sue from 5 brain regions: striatum, mid-brain, cerebel-
lum, superior temporal gyrus (STG) and superior frontal
gyrus (SFG). Average levels of DNA methylation in the
DRD4 region in our sample were as follows: Striatum
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Figure 4 Average percentage DNA methylation across CpG sites in the DRD4 region by genotype groups at 4 associated SNPs. Error
bars denote standard deviation. * = significant associations at the p < 0.05 level. Though association analyses were conducted on arcsine
transformed data, the true proportion of methylation observed is plotted here. The one homozygous TT subject at rs752306 within our sample
was collapsed with the heterozygote group in association analyses.
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d = 0.05; Cerebellum mean= 0.52, s.d = 0.06, STG
mean=0.54, s.d = 0.03, SFG mean=0.56, s.d = 0.06. The
SNP-association results are given in Table 3. One-tailed p-
values are provided as we expected effects in the sameTable 3 Associations of rs3758653 and rs936465 with averag
SNP Tissue N Mean AA (N)
rs3758653 Striatum 13 0.47 (2)
Mid-brain 8 0.38 (1)
Cerebellum 9 0.51 (2)
STG 12 0.52 (1)
SFG 9 0.48 (2)
rs936465 Striatum 13 0.56 (3)
Mid-brain 8 0.52 (3)
Cerebellum 9 0.56 (3)
STG 12 0.55 (5)
SFG 10 0.6 (3)direction as was observed in the CEPH transformed lym-
phoblastoid cell line DNA. Of the 10 association results, 8
followed the same direction of effect as the original SNP
associations. Nominally significant associations (p< 0.05)
were found between rs3758653 and SFG DNAe DRD4 DNA methylation in post-mortem brain tissue
Mean AB (N) Mean BB (N) F P-value
0.57 (3) 0.51 (8) 0.03 0.433
0.53 (2) 0.48 (5) 0.06 0.590
NA (0) 0.53 (7) 0.10 0.382
0.57 (3) 0.52 (8) 3.05 0.944
0.59 (1) 0.57 (7) 6.51 0.017
0.5 (7) 0.53 (3) 0.09 0.384
0.46 (4) 0.42 (1) 5.82 0.038
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P-value= 0.017), and between rs936465 and Mid-brain
(N=9; d.f. = 1 and 7; F = 6.51; r2 = 0.44; P-value= 0.017)
and STG DNA methylation (N=12; d.f. = 1 and 10;
F = 6.31; r2 = 0.39; P-value= 0.015). Again, the effect sizes
were large, with the SNPs accounting for 39-45% of the
variation in DNA methylation (rs3758653: Allele A=C, Al-
lele B =T; rs936465: Allele A=C, Allele B = G. STG= Sin-
gular Temporal Gyrus; SFG = Singular Frontal Gyrus);
however the absolute differences in DNA methylation
were small to moderate, the sample size was small and the
associations did not remain significant after Bonferroni
correction for the 10 tests conducted. Although analyses
utilized transformed data, the true DNA methylation
levels are given here. Where only one homozygote was
available, this subject was combined with the heterozy-
gotes for analyses. The one rs3758653 heterozygote with
SFG methylation data was combined with the TT homo-
zygote group for analyses. One-tailed p-values are
provided.
Figures 6 and 7 display the nominally significant asso-
ciations of rs3758653 and rs936465 with average DRD4DNA methylation in post-mortem brain tissue, as well
as the associations of these SNPs with individual CpG
sites within the DRD4 region. Comparison with data
from the CEPH sample indicates not only a similar pat-
tern of association results, but also a similar pattern of
DNA methylation levels across the DRD4 CpG sites.
Discusion
Our investigation uncovered significant SNP associations
with DNA methylation levels in the DRD4 promoter,
which were replicated at a nominal level of significance
(p < 0.05) in an independent sample of post-mortem
brain tissue. As with the majority of genetic effects iden-
tified in previous studies, these SNP associations oc-
curred in cis [20,26-32]. As cis-acting genetic influence
over DNA methylation has been observed throughout
the genome, it may account for many previously unex-
plained genetic associations. Though we did not analyse
trans-acting SNPs in the present study, trans genetic
effects are also likely to be important [26,35].
The greatest group difference in DNA methylation
was 16%, between the two rs3758653 homozygote
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Figure 6 DRD4 percentage DNA methylation levels in CEPH transformed lymphoblastoid cell lines and post-mortem Singular Frontal
Gyrus tissue (SFG). a) Average DRD4 DNA methylation levels plotted by rs3802971 genotype b) DNA methylation levels across individual DRD4
CpG sites plotted by rs3802971 genotype group. * = significant associations at the p < 0.05 level. Though arcsine transformed data were used in
analyses, the true proportion of DNA methylation observed is plotted here. The one heterozygous subject in the post-mortem brain tissue
sample was combined with the TT homozygotes for analyses.
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tional relevance of these small changes in DNA methyla-
tion is unknown. If one is attempting to find an
influential locus of large effect, substantial changes in
DNA methylation levels may be expected. However, as
most complex phenotypes are now thought to be influ-
enced by a myriad of factors of small effect [53,54], more
subtle differences in DNA methylation levels may be im-
portant. Our knowledge is still very limited, but as a
~20% difference in DNA methylation has been previ-
ously shown to associate with a 2-fold change in gene
expression [35,55], or even to bring about the presence
or complete absence of gene expression across various
tissues [56], it is likely that individual differences in
phenotypic outcome will be cumulatively influenced bymany small differences in the epigenetic, and conse-
quently the transcriptomic, landscape. Detecting genetic
influences over even more modest individual differences
in DNA methylation than observed here will require far
larger samples.
It is likely that cis-acting DNA effects on DNA methy-
lation are more important in some genomic regions than
in others [22,26,33,35], and our findings suggest that
DRD4 may represent a region in which cis-acting
genetic-control commonly occurs. Although previous
genomewide association studies of DNA methylation
have not reported positive results from the DRD4 region
[10,17,19], such investigations may be limited in the
CpGs and SNPs they were able to investigate by the la-
boratory platforms used. The DRD4 SNPs tested did not
020
40
60
80
100
CEPH cell line
rs936465
Pe
rc
en
ta
ge
 m
et
hy
la
tio
n
CC CG GG
0
20
40
60
80
100
a
0
20
40
60
80
100
Mid-brain
rs936465
Pe
rc
en
ta
ge
 m
et
hy
la
tio
n
CC CG/GG
0
20
40
60
80
100
0
20
40
60
80
100
STG
rs936465
Pe
rc
en
ta
ge
 m
et
hy
la
tio
n
CC CG GG
0
20
40
60
80
100
0
20
40
60
80
100
CEPH cell line
CpG units
Pe
rc
en
ta
ge
 m
et
hy
la
tio
n
0
20
40
60
80
100
8 9
12
.1
3.
14
15
.1
6.
17
21
.2
2.
23 32 36
37
.3
8 39
Av
er
ag
e
b
0
20
40
60
80
100
Mid-brain
CpG units
Pe
rc
en
ta
ge
 m
et
hy
la
tio
n
0
20
40
60
80
100
8 9
12
.1
3.
14
15
.1
6.
17
21
.2
2.
23 32 36
37
.3
8 39
Av
er
ag
e
0
20
40
60
80
100
STG
CpG units
Pe
rc
en
ta
ge
 m
et
hy
la
tio
n
0
20
40
60
80
100
8 9
12
.1
3.
14
15
.1
6.
17
21
.2
2.
23 32 36
37
.3
8 39
Av
er
ag
e
Figure 7 DRD4 percentage DNA methylation levels in CEPH transformed lymphoblastoid cell lines and post-mortem Mid-brain and
Singular Temporal Gyrus tissue (STG). a) Average DRD4 DNA methylation levels plotted by rs936465 genotype b) DNA methylation levels
across individual DRD4 CpG sites plotted by rs936465 genotype group. * = significant associations at the p < 0.05 level. Though arcsine
transformed data were used in analyses, the true proportion of DNA methylation observed is plotted here. The one subject with available
mid-brain DNA methylation data who was GG homozygous at rs936465 was combined with the heterozygotes for analyses.
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base [51], and although we found DRD4 SNP associa-
tions with DNA methylation in our independent
replication sample, they did not withstand Bonferroni cor-
rection for multiple testing. Furthermore, the findings of a
recent twin study of the same DRD4-associated region
assayed here are inconsistent with those we have reported.
Wong et al.’s investigation of DNA methylation in 46 MZ
and 45 DZ twins indicated no heritable element was
involved [42]. Differences in the sample and tissue types
used across the two studies are likely to explain the dispar-
ate findings. Additionally, all investigations of this region
to date – including the present study – have involved ex-
tremely small sample sizes. Future work will require far lar-
ger samples in order to draw firm conclusions.
One limitation of this study was the modest size of
both the discovery and replication samples. Our discov-
ery sample had 80% power to detect causal QTLs of
9.6% effect size, or markers in linkage disequilibrium
(D’= 0.8) with causal QTLs of 15.1% effect size. As sub-
jects were drawn from the extensively characterized
CEPH sample, we were more likely to have access to the
genotypes of causal variants. Furthermore, one mightexpect cis-acting SNPs to show larger effects over local
DNA methylation than over complex disease pheno-
types. Nonetheless, as DNA methylation levels are likely
be subject to the effects of multiple environmental, cis
and trans genetic, and also stochastic factors, far smaller
effect sizes may be involved than the sample was
equipped to detect. Though we excluded SNPs with
MAFs below 5%, the MAF of one of the SNPs associated
with DNA methylation was lower than 10% (rs752306 -
see Table 1), further stretching the power of our sample.
Our replication sample was also limited in size, with
the analyses involving the largest N of 13 having only
80% power to detect a causal QTL of 53% effect size.
Though we did detect nominal SNP associations, we feel
our replication sample was too small to draw final con-
clusions. Unfortunately, the laboratory techniques used
to assess DNA methylation are relatively new and still
rapidly developing, and both genetically and epigeneti-
cally assessing samples involves considerable cost and
labour. Consequently, to date the investigations of gen-
etic influences over DNA methylation have all involved
similarly small sample sizes [20,22,26,30,33,35,42]. Wis-
dom gained from studies of other complex phenotypes
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ger sample sizes if they hope to detect the expected
small effects [53,57,58]. This wisdom can also be applied
when interpreting the relatively large effect sizes (8.4-
14.8%) we did manage to detect in our small discovery
sample, and the even larger effect sizes (39-44%) we
observed in our replication sample. Though many sig-
nificant associations between candidate genes and com-
plex traits have been identified and replicated over the
years, the large effect sizes originally reported in discov-
ery samples often fall as sample sizes, and number of
replication studies, increase [3]. We would therefore ex-
pect the effects found in any future investigations of lar-
ger samples to be smaller than those reported here.
Our small sample size also restricted the statistical
analyses we were able to perform. Firstly, although we
would not expect to find significant population stratifi-
cation within our CEPH participants, the small sample
size did not permit us to test this empirically. Secondly,
though we controlled for the effects of genetic related-
ness and nuclear family environment in our association
analyses, our sample was too small to simultaneously es-
timate many variance parameters accurately. As a result,
in many cases the effect of the family environment could
not be reliably distinguished from the effects of genetic
relatedness in our sample. Although the influence of the
environment over DNA methylation is well documented
[59], we predicted that it would be less significant in the
transformed lymphoblastoid cell line DNA used here. In-
deed, after controlling for genetic relatedness in our ana-
lyses, the family environment often showed no additional
influence over DNA methylation. Our modest sample size
also left us unable to take parent of origin effects into ac-
count, which recent computational analyses suggest are
prevalent across the genome [60]. The stringent Bonferroni
method used for multiple-testing correction in our replica-
tion sample may also be seen as a limitation, as the 5 tis-
sues tested came from largely the same participants.
However, DNA methylation across the 5 brain regions
within individuals was uncorrelated, likely to be in part due
to low levels of variation in our sample.
The quantitative DNA methylation data generated using
the MALDI-TOF-based Sequenom EpiTyper technique
were limited in a number of ways. As Additional File 1
demonstrates, due to the position of cut sites, after base-
specific RNA cleavage some adjacent CpGs remained on
the same fragment [33,34]. As a result, many of the CpG
units assessed – including some of those exhibiting signifi-
cant SNP associations – consisted of average DNA methy-
lation measurements across several CpG sites. Additional
File 1 also highlights the exclusion of numerous CpG-
containing fragments for a variety of reasons. Since the
present study was conducted, R packages such as RSeq-
Meth [44] and MassArray [61] have been created to assistresearchers in designing assays which avoid at least some
of this loss of data. Furthermore, an optimal method for
examining associations between genetic markers and
DNA methylation would examine allele-specific methyla-
tion The interpretation of results from future studies
might be aided by an approach which uses resources such
as SCAN to select known eQTLs for tests of association
with DNA methylation levels [51].
The source of the DNA used in our discovery sample
represents another possible limitation. The aim of this
study was to assess the influence of DNA sequence over
DNA methylation in 5 genomic regions. By assessing
DNA methylation in the CEPH sample, we had the op-
portunity to investigate a large number of SNPs at no
extra cost to our laboratory. However, comparisons of
RNA extracted from transformed lymphoblastoid cell
lines to that extracted directly from blood cells have
revealed significant differences in gene expression [62].
Moreover, when DNA methylation in lymphoblastoid
cell lines from type 1 diabetes patients was compared
with that in paired peripheral blood leucocytes, differ-
ences were observed in 8% of the genes assessed [63].
The SNP associations identified here may therefore not
apply to in vivo DNA methylation levels. Despite this,
we nominally replicated the two SNP associations emer-
ging from the analysis of the CEPH sample, in DNA
derived from brain tissue. It is also worth noting that
Figures 6 and 7 indicate very similar patterns of DRD4
DNA methylation in the cell line and brain-tissue
derived DNA analysed here. Furthermore, a 2010 study
of the exact DRD4 region studied here found similar
levels of methylation in DNA extracted from buccal
swabs [42], suggesting that the results of DNA methyla-
tion analyses in transformed lymphoblastoid cell lines
may be relevant in vivo.
Future investigations will benefit from an approach
similar to that used in Schalkwyk et al.’s 2010 study,
which assesses the effects of different alleles within the
same individual [35,64]. This enables a test of SNP asso-
ciation against a background controlled entirely for all
environmental and other genetic factors, and unlike our
approach, in heterozygotes at least it can expressly iden-
tify DNA methylation differences across the two separate
DNA strands. As none of the SNPs identified in our
study are known to effect the expression of proximal
genes, it is difficult to draw conclusions regarding the ef-
fect of the associations with DNA methylation that we
have observed. The interpretation of results from future
studies might be aided by an approach which uses
resources such as SCAN to select known eQTLs for
tests of association with DNA methylation levels [51].
Although the limitations of transformed lymphoblastoid
cell line DNA have been discussed above, and though we
did not consider disease phenotypes in our analyses, our
Docherty et al. Behavioral and Brain Functions 2012, 8:31 Page 12 of 13
http://www.behavioralandbrainfunctions.com/content/8/1/31findings may have implications for research into DRD4 dis-
ease-associations, especially given the nominally significant
associations we found in post-mortem brain tissue. DRD4
has been previously linked to a number of psychiatric and
behavioural disorders, most notably ADHD [2]. Much of
the emphasis has been upon the exon 3 VNTR [3], yet
SNPs in the DRD4 promoter have also shown significant
associations with ADHD [4,5], schizophrenia [8,9] and
fibromyalgia [65]. Interestingly, two SNPs tagged in this
study have emerged previously in the literature (see
Figure 3); rs936465 is in LD (r2 of 0.96) with rs4331145,
which has been implicated in schizophrenia [9], and
rs11246226 (r2 of 0.55), which has been implicated in
schizophrenia and fibromyalgia [9,65]. DNA methylation
has been suggested as a mediator of well-known environ-
mental influences over disease phenotypes such as ADHD
[59,66,67]. Our results suggest that epigenetic processes
may mediate previously identified, but as yet unexplained,
genetic influences too.
Conclusions
We have reported SNP associations with DNA methyla-
tion levels in the DRD4 gene region. Although replica-
tion is needed in larger samples, our findings add to the
existing literature linking genetic sequence to DNA
methylation patterns. DRD4 has been implicated in a
number of disease phenotypes, and our results offer a
possible mechanism of action for previously unexplained
SNP associations in these regions.
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